Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes
- 31 December 2008
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 20 (12), 2231-2236
- https://doi.org/10.1016/j.cellsig.2008.08.012
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac MyocytesCirculation, 2006
- Polycistronic RNA polymerase II expression vectors for RNA interference based on BIC/miR-155Nucleic Acids Research, 2006
- Sildenafil Inhibits β-Adrenergic–Stimulated Cardiac Contractility in HumansCirculation, 2005
- Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse HeartsPublished by Elsevier BV ,2003
- Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5): Differential tissue distribution and subcellular localization of PDE9A variantsGene, 2003
- Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse HeartCirculation Research, 2003
- Sildenafil citrate does not affect cardiac contractility in human or dog heartCurrent Medical Research and Opinion, 2003
- Role of cyclic GMP‐dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytesJournal Of Physiology-London, 2002
- Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failureThe FASEB Journal, 2001
- Identification, Quantitation, and Cellular Localization of PDE1 Calmodulin-Stimulated Cyclic Nucleotide PhosphodiesterasesMethods, 1998